SCHEMBL1714210

SCHEMBL1714210

[CH2]C=COCC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1714209 1.00
SCHEMBL1407388 0.78
SCHEMBL8052611 0.78
SCHEMBL1407387 0.78
SCHEMBL10958644 0.75
SCHEMBL8022635 0.75
SCHEMBL6109145 0.74 CASP1 (0.30)
SCHEMBL8966068 0.72
SCHEMBL3904068 0.69
SCHEMBL1285093 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 110 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240217923-A1 A DIISOCYANATE STABILIZER, USE THEREOF, AND DIISOCYANATE COMPOSITION BASF (CHINA) COMPANY LIMITED (CN) 2024-07-04 US disclosed
EP-4330226-A1 A DIISOCYANATE STABILIZER, USE THEREOF, AND DIISOCYANATE COMPOSITION BASF SE (DE) 2024-03-06 EP disclosed
WO-2024012851-A1 SUSTAINABLE ANTIOXIDANT COMPOSITION, USE THEREOF AND POLYMER COMPOSITION COMPRISING THE SAME BASF SE (DE) 2024-01-18 WO disclosed
CN-117203185-A Diisocyanate stabilizer, use thereof and diisocyanate composition 巴斯夫欧洲公司 2023-12-08 CN disclosed
CN-107001654-B Method for curing curable composition 巴斯夫欧洲公司 2020-11-20 CN disclosed
US-10577471-B2 Method for curing curable compositions BASF SE (DE) 2020-03-03 US disclosed
CN-106957317-B Novel pyrazole derivatives 持田制药株式会社 2019-12-31 CN disclosed
EP-3201261-B1 METHOD FOR CURING CURABLE COMPOSITIONS BASF SE (DE) 2018-12-12 EP disclosed
EP-2132244-B1 METHOD FOR PRODUCING COLORLESS ISOCYANURATES OF DIISOCYANATES BASF SE (DE) 2018-08-22 EP disclosed
US-20180148554-A9 METHOD FOR CURING CURABLE COMPOSITIONS BASF SE (DE) 2018-05-31 US disclosed
US-5719141-A HYPOTENSIVE AGENTS NOVARTIS CORPORATION (US) 1998-02-17 US disclosed
EP-0702004-A2 2,9-diamino- and 2-amino-8-carbamoyl-4-hydroxy-alkanoic acid amid derivatives CIBA-GEIGY AG (CH) 1996-03-20 EP disclosed
EP-0640083-A1 SUBSTITUTED PYRIDO 1,2-A]PYRIMIDINONE DERIVATIVES AS FUNGICIDES E.I. DU PONT DE NEMOURS AND COMPANY (US) 1995-03-01 EP disclosed
WO-1993023398-A1 SUBSTITUTED PYRIDO[1,2-A]PYRIMIDINONE DERIVATIVES AS FUNGICIDES E.I. DU PONT DE NEMOURS AND COMPANY (US) 1993-11-25 WO disclosed
CN-1015983-B Process for preparing gametocides pyrazoles LILLY CO ELI (US) 1992-03-25 CN disclosed
EP-0407342-A2 Pyrimidine derivatives CIBA-GEIGY AG (CH) 1991-01-09 EP disclosed
CN-87102443-A Cametocidal pyrazoles 1987-10-14 CN disclosed
US-4410530-A CARDIO-SELECTIVE B-RECEPTOR BLOCKING AGENTS AND STIMULANTS CIBA-GEIGY CORPORATION (US) 1983-10-18 US disclosed
US-4195090-A ADRENERGIC BLOCKING AGENTS CIBA-GEIGY CORPORATION (US) 1980-03-25 US disclosed
US-4115575-A CARDIOVASCULAR DISORDERS CIBA-GEIGY CORPORATION (US) 1978-09-19 US disclosed